Reuven Agami

25.6k citations
127 papers · 19.9k indexed · 9 hit papers · h-index 57
Topics
RNA modifications and cancer (50 papers)MicroRNA in disease regulation (40 papers)RNA Research and Splicing (38 papers)

In The Last Decade

Reuven Agami

124 papers receiving 19.5k citations

Hit Papers

A System for Stable Expression of Short Interfering RNAs ...20022026201020182002200620022004200810002.0k3.0k

Peers

Reuven Agami
Comparison fields: 5 of 150
  • Molecular Biology 16.6k
  • Cancer Research 7.5k
  • Oncology 2.7k
  • Genetics 1.9k
  • Immunology 1.3k
Replace Lewis A. Chodosh with:
Lewis A. Chodosh United States
Peggy Farnham United States
Li Ma China
George W. Bell United States
Anindya Dutta United States
Wen Xue China
David D.L. Bowtell Australia
Shunichi Takeda Japan
Patrice J. Morin United States
Martin Eilers Germany
Reuven Agami relative to Lewis A. Chodosh United States Lewis A. Chodosh's profile →
Citations per field
00.5×1.5×2.4×
Lewis A. Chodosh · 1×
Citations per year

Countries citing papers authored by Reuven Agami

Since Specialization
Citations

This map shows the geographic impact of Reuven Agami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reuven Agami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reuven Agami more than expected).

Fields of papers citing papers by Reuven Agami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reuven Agami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reuven Agami. The network helps show where Reuven Agami may publish in the future.

Co-authorship network of co-authors of Reuven Agami

This figure shows the co-authorship network connecting the top 25 collaborators of Reuven Agami. A scholar is included among the top collaborators of Reuven Agami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reuven Agami. Reuven Agami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 51
4 11
5 9
6 38
7 44
8 4
9 18
10 94
11 12
12 36
13 94
14 214
15 83
16 392
17
The micrornas mir-373 and mir-520c promote tumor migration, invasion and metastasis
1
18
RNA-Binding Protein Dnd1 Inhibits MicroRNA Access to Target mRNAbreakdown →
591
19
A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell Tumorsbreakdown →
1023
20 220

About Reuven Agami

Reuven Agami is a scholar working on Cancer Research, Molecular Biology and Aging, having authored 127 papers that have together received 19.9k indexed citations. Recurring topics across this work include RNA modifications and cancer (50 papers), MicroRNA in disease regulation (40 papers) and RNA Research and Splicing (38 papers). The work is most often cited by research in Cancer Research (7.5k citations), Molecular Biology (16.6k citations) and Oncology (2.7k citations). Reuven Agami has collaborated with scholars based in Netherlands, Israel and United States. Frequent co-authors include René Bernards, Thijn R. Brummelkamp, Carlos le Sage, Ran Elkon, Martijn Kedde, Remco Nagel, Mariëtte Schrier, P. Mathijs Voorhoeve, Alejandro P. Ugalde and Joachim A.F. Oude Vrielink. Their work appears in journals such as Nature, Science and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026